We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

The Importance of Translating Research Skillfully to Benefit the Public

Rainbow Vogt, PhD
Arch Intern Med. 2012;172(5):449-450. doi:10.1001/archinternmed.2011.1864.
Text Size: A A A
Published online


The recent article “Dietary Supplements and Mortality Rate in Older Women”1 reported increased mortality associated with use of vitamin supplements, and the message to fear supplements was echoed throughout major media outlets. In response to the study findings that were admittedly inconclusive by the authors because of the weak association between mortality and supplementation, Rita Redberg, MD, MSc,2 noted that the Dietary Supplement Health and Education Act “allows” Americans to spend in excess of $20 billion annually for dietary supplements, missing the irony that this is less than 10% of the amount spent on pharmaceuticals annually and less than 1% of the annual US health care expenditure. Ironic still is that vitamin deficiency–related disease is so common that pharmaceuticals are now being formulated specifically for vitamin deficiencies.3 For example, a company called Cytochroma is currently developing a drug with the purpose of treating vitamin D deficiencies. Glenville Jones, PhD, is a coinventor of this drug and also contributed to the 2010 Institute of Medicine report4 discouraging large doses of vitamin D by reporting that a blood concentration of 50 nmol/L of 25-hydroxyvitamin D (25[OH]D) (to convert to nanograms per milliliter, divide by 2.496) is sufficient for disease prevention. In actuality, the concentration needed to prevent deficiency disease including osteoporosis, cancer, cardiovascular disease, and autoimmune diseases is 75 nmol/L of 25(OH)D,5 as recommended by the International Osteoporosis Foundation. Considering that millions of deaths have been attributed to pharmaceuticals6 and virtually none to vitamin supplementation,7 why would the research community risk confusing the American public with the message to fear supplementation?



Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





March 12, 2012
Jaakko Mursu, PhD; David R. Jacobs, PhD
Arch Intern Med. 2012;172(5):449-450. doi:10.1001/archinternmed.2012.39.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles